Idorsia Company
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Employee Number:
501-1000
Headquarters:
Allschwil, Basel-Landschaft, Switzerland, Europe
Founded Date:
2017-06-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41 58 844 00 00
Investors:
CARB-X, Jean-Paul Clozel, Pharmakon Advisors
Ipo Status:
public
Stock Symbol:
IDIA
City:
Allschwil
Region:
Basel-Landschaft
Country:
Switzerland
Founders:
Jean-Paul Clozel, Martine Clozel
Number Of Investment/Funding Rounds:
2